Literature DB >> 29383676

Regulation, signalling and functions of hormonal peptides in pulmonary vascular remodelling during hypoxia.

Priya Gaur1, Supriya Saini1, Praveen Vats2, Bhuvnesh Kumar1.   

Abstract

Hypoxic state affects organism primarily by decreasing the amount of oxygen reaching the cells and tissues. To adjust with changing environment organism undergoes mechanisms which are necessary for acclimatization to hypoxic stress. Pulmonary vascular remodelling is one such mechanism controlled by hormonal peptides present in blood circulation for acclimatization. Activation of peptides regulates constriction and relaxation of blood vessels of pulmonary and systemic circulation. Thus, understanding of vascular tone maintenance and hypoxic pulmonary vasoconstriction like pathophysiological condition during hypoxia is of prime importance. Endothelin-1 (ET-1), atrial natriuretic peptide (ANP), and renin angiotensin system (RAS) function, their receptor functioning and signalling during hypoxia in different body parts point them as disease markers. In vivo and in vitro studies have helped understanding the mechanism of hormonal peptides for better acclimatization to hypoxic stress and interventions for better management of vascular remodelling in different models like cell, rat, and human is discussed in this review.

Entities:  

Keywords:  Angiotensin II; Arginine vasopressin; Atrial natriuretic peptide; Endothelin-1; Hypoxia; Pulmonary vascular remodelling

Mesh:

Substances:

Year:  2018        PMID: 29383676     DOI: 10.1007/s12020-018-1529-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  139 in total

1.  The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Authors:  S AbdAlla; H Lother; A M Abdel-tawab; U Quitterer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

2.  Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness.

Authors:  P Bärtsch; M Maggiorini; W Schobersberger; S Shaw; W Rascher; J Girard; P Weidmann; O Oelz
Journal:  J Appl Physiol (1985)       Date:  1991-07

Review 3.  K+ channel modulation in arterial smooth muscle.

Authors:  N B Standen; J M Quayle
Journal:  Acta Physiol Scand       Date:  1998-12

4.  Mechanism of endothelin-1-induced pulmonary vasoconstriction.

Authors:  M J Horgan; J M Pinheiro; A B Malik
Journal:  Circ Res       Date:  1991-07       Impact factor: 17.367

5.  Effect of alpha- and beta-adrenergic blocking agents on the increase in renin secretion produced by stimulation of the renal nerves.

Authors:  J R Loeffler; J R Stockigt; W F Ganong
Journal:  Neuroendocrinology       Date:  1972       Impact factor: 4.914

Review 6.  Non-genomic actions of aldosterone: from receptors and signals to membrane targets.

Authors:  Ruth Dooley; Brian J Harvey; Warren Thomas
Journal:  Mol Cell Endocrinol       Date:  2011-07-27       Impact factor: 4.102

Review 7.  Renin-angiotensin-aldosterone system and progression of renal disease.

Authors:  Christiane Rüster; Gunter Wolf
Journal:  J Am Soc Nephrol       Date:  2006-10-11       Impact factor: 10.121

Review 8.  Mechanisms of sympathetic activation and blood pressure elevation by intermittent hypoxia.

Authors:  Nanduri R Prabhakar; Ganesh K Kumar
Journal:  Respir Physiol Neurobiol       Date:  2010-09-08       Impact factor: 1.931

Review 9.  Atrial natriuretic peptide in hypoxia.

Authors:  Yiu-Fai Chen
Journal:  Peptides       Date:  2005-04-18       Impact factor: 3.750

Review 10.  Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption.

Authors:  Michelle Boone; Peter M T Deen
Journal:  Pflugers Arch       Date:  2008-04-23       Impact factor: 3.657

View more
  4 in total

1.  Angiogenic signaling in the lungs of a metabolically suppressed hibernating mammal (Ictidomys tridecemlineatus).

Authors:  Samantha M Logan; Kenneth B Storey
Journal:  PeerJ       Date:  2019-11-18       Impact factor: 2.984

2.  The chest CT features of coronavirus disease 2019 (COVID-19) in China: a meta-analysis of 19 retrospective studies.

Authors:  Haitao Yang; Yuzhu Lan; Xiujuan Yao; Sheng Lin; Baosong Xie
Journal:  Virol J       Date:  2020-10-21       Impact factor: 4.099

3.  Non-immune Prophylaxis Against COVID-19 by Targeting Tolerance for Angiotensin II-Triggered SARS-CoV-2 Pathogenesis.

Authors:  Michael V Dubina
Journal:  Front Med (Lausanne)       Date:  2022-01-12

Review 4.  Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).

Authors:  Arno R Bourgonje; Amaal E Abdulle; Wim Timens; Jan-Luuk Hillebrands; Gerjan J Navis; Sanne J Gordijn; Marieke C Bolling; Gerard Dijkstra; Adriaan A Voors; Albert Dme Osterhaus; Peter Hj van der Voort; Douwe J Mulder; Harry van Goor
Journal:  J Pathol       Date:  2020-06-10       Impact factor: 9.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.